About this approach
Medicinal mushroom products include extracts and compounds from several species. They differ from each other and from mushrooms eaten as food. Some standardized products have been studied alongside conventional cancer treatment, while many retail blends make broader immune or anticancer claims. Evidence for a particular preparation cannot be transferred to every powder, capsule or combination.
Where it fits: Product-specific adjunct research; commercial products are not interchangeable
Where this treatment is used
NCI describes research on specific mushroom-derived products, including polysaccharide-K, or PSK, which has been used as an approved adjunct cancer product in Japan. Studies of PSK with conventional therapy in selected settings have reported benefits, but the findings are tied to the product, cancer type and accompanying treatment. MSK similarly distinguishes standardized preparations such as PSK and PSP from broader supplement claims. Changes in immune-cell measurements are not, by themselves, proof of improved survival.
Procedure and practical considerations
Adverse effects and interactions vary with the species and preparation. Digestive symptoms, allergic reactions and differences in product quality need consideration. A blend may contain additional herbs or ingredients that are not obvious from its name. People receiving immune-modifying treatment should have the whole product reviewed rather than assuming immune stimulation is desirable.
Clinics reporting this approach
These clinic profiles mention this approach in their published materials. Open a profile to compare locations, services, practical details, and ways to get started.
Sources
Source information checked: 2026-09-29. The links below identify the public and clinic-provided materials used for this page.
- NCI: Medicinal Mushrooms PDQ ↗Checked 2026-09-29
- MSK: Coriolus versicolor ↗Checked 2026-09-29
How Cancer Clinic Finder compiles information · Suggest a factual correction